MDXG
Mimedx Group, Inc.Company with tickers: MDXG
CIK
1376339
CUSIP
602496101
Shares Outstanding
148,945,731
Website
https://www.mimedx.com
13F Activity (30d)
6 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$100,000,000
as of 2026-02-28
Remaining Authorization
$13,000
as of 2017-09-30
· not restated in filings since 2017-10-31
Program Utilization
100.0%
$99,987,000 used of $100,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2023-12-31 | $9,515,000 | 10-K, filed 2026-02-25 |
| 2022-12-31 | $0 | 10-K, filed 2025-02-26 |
| 2021-12-31 | $0 | 10-K, filed 2024-02-28 |
| 2020-12-31 | $900,000 | 10-K, filed 2021-03-08 |
| 2018-12-31 | $7,600,000 | 10-K, filed 2021-03-08 |
| 2017-12-31 | $68,300,000 | 10-K, filed 2020-07-06 |
| 2016-12-31 | $10,400,000 | 10-K, filed 2020-03-17 |
| 2016-03-31 | $49,244,000 | 10-Q, filed 2016-05-10 |
| 2015-12-31 | $40,143,000 | 10-K, filed 2017-02-22 |
| 2015-09-30 | $26,585,000 | 10-Q, filed 2015-11-06 |